Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
---|
08/01/2002 | US20020103357 Nucleotide sequences coding enzymatic polypeptide for use in the generation of preferential amino acids, medicines and human nutrients |
08/01/2002 | US20020103351 32146 and 57259, novel human transporters and uses therefor |
08/01/2002 | US20020103340 Rab proteins |
08/01/2002 | US20020103337 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
08/01/2002 | US20020103336 Cloning of chicken anemia dna |
08/01/2002 | US20020103121 Amino acid sequence of residues 163-199 used to induce apoptosis in a cell |
08/01/2002 | US20020103115 Useful in the development of human therapeutics and diagnostic compositions and methods |
08/01/2002 | US20020102726 Which forms a reconstructed epidermis, used to test various factors on human skin equivalent, such as drugs, cosmetics, surfactants and detergents |
08/01/2002 | US20020102722 Lac shuttle vectors |
08/01/2002 | US20020102712 Nucleotide sequences coding enzymatic polypeptide for use in the treatment of viral diseases |
08/01/2002 | US20020102711 Polypeptide for use in the treatment of cancer and immunological |
08/01/2002 | US20020102707 Nucleotide sequences coding polypeptide for use in the treatment of sexual disorders |
08/01/2002 | US20020102702 Enzymatic polypeptide for use in the detergents |
08/01/2002 | US20020102698 Gene encoding alkaline liquefying alpha-amylase |
08/01/2002 | US20020102697 Genes encoding exopolysaccharide production |
08/01/2002 | US20020102696 Recombinant thermostable enzyme which forms non-reducing saccharide from reducing amylaceous saccharide |
08/01/2002 | US20020102691 Enzymatic polypeptide for use in treatment and prevention of, heart liver and inflammatory disorders |
08/01/2002 | US20020102690 Genes involved in isoprenoid compound production |
08/01/2002 | US20020102688 Nucleotide sequences coding polypeptide for use as anticoagulant and antiseptic |
08/01/2002 | US20020102684 Human phospholipase inhibitor |
08/01/2002 | US20020102680 Nucleotide sequences coding enzymatcic polypeptide for use in paper making and cleaning contact lenses |
08/01/2002 | US20020102676 Nucleotide sequences coding membrane proteins for use in cancer therapy |
08/01/2002 | US20020102670 DNA coding for protein which confers on bacterium Escherichia coli resistance to L-homoserine, and method for producing L-amino acids |
08/01/2002 | US20020102655 Simultaneous expression of both the heterologous protein, including functional membrane proteins, and a means for compartmentalizing or sequestering of the protein |
08/01/2002 | US20020102653 DNA coding for human cell surface antigen |
08/01/2002 | US20020102652 Polypeptide for use in the diagnosis, prevention and treatment of tumors and autoimmune diseases |
08/01/2002 | US20020102651 Novel B7-4 molecules and uses therefor |
08/01/2002 | US20020102649 Human transport protein homologs |
08/01/2002 | US20020102647 Nucleotide sequences coding membrane protein for use in treatment of nervous system disorders and arthritis |
08/01/2002 | US20020102645 Novel member of the lysyl oxidase gene family |
08/01/2002 | US20020102643 Dorsal tissue affecting factor and compositions |
08/01/2002 | US20020102642 Nuclelotide sequences coding preferential protein for use in therapeutic, diagnostic and medical imaging |
08/01/2002 | US20020102640 Nucleotide sequences coding preferential protein for use in the diagnosis, prevention and treatment of cancer |
08/01/2002 | US20020102636 Promoter can regulate gene expression under various carbohydrate conditions; vector for transformation of a foreign gene or R. oryzae |
08/01/2002 | US20020102635 Methods for making and using a thermophilic enzyme as a beta-glycosidase |
08/01/2002 | US20020102634 Human stanniocalcin-alpha |
08/01/2002 | US20020102633 Polypeptide for use in the treatment bone disorders and osteoarthritis |
08/01/2002 | US20020102618 Drosophila derived receptors of the steroid receptor superfamily |
08/01/2002 | US20020102604 Full-length human cDNAs encoding potentially secreted proteins |
08/01/2002 | US20020102603 Compositions and methods for the treatment and diagnosis of cardiovascular disease |
08/01/2002 | US20020102569 Nucleotide sequences for use in the detection, classificataions, treatment and evaluation of cancer therapies |
08/01/2002 | US20020102560 Nucleotide sequences coding enzymatic polypeptide for use in treatment metastasis and tumors |
08/01/2002 | US20020102540 Functional dna clone for hepatitis c virus (hcv) and uses thereof |
08/01/2002 | US20020102276 For diagnosis, therapy and prophylaxis of Neisseria meningitidis infection; vaccine |
08/01/2002 | US20020102270 Chlamydia antigens and corresponding DNA fragments and uses thereof |
08/01/2002 | US20020102269 Contacting a parental Helicobacter with molecule in biological sample, testing and comparing response to extracellular pH and sensitivity to acidity of parental strain to a strain deficient in UreI; selecting molecule |
08/01/2002 | US20020102252 Novel isoforms of human pregnancy-associated protein-E |
08/01/2002 | DE10110760A1 Neue für das otsA-Gen kodierende Nukleotidsequenzen New coding for the otsA gene nucleotide sequences |
08/01/2002 | DE10101962A1 DNA-Sequenz mit regulatorischen Bereichen zur Expression von Proteinen DNA sequence with regulatory regions for expression of proteins |
08/01/2002 | DE10101793A1 Verwendung von SLPI zur Behandlung chronisch-entzündlicher Darmerkrankungen Use of SLPI in the treatment of chronic inflammatory bowel disease |
08/01/2002 | DE10101501A1 Verfahren zur fermentativen Herstellung von Pantothensäure A process for the fermentative production of pantothenic acid |
08/01/2002 | CA2442602A1 Probiotic compounds derived from lactobacillus casei strain ke01 |
08/01/2002 | CA2440703A1 Methods of diagnosis of breast cancer, compositions and methods of screening for modulators of breast cancer |
08/01/2002 | CA2436091A1 Neutralizing human monoclonal antibodies against hiv-1, their production and uses |
08/01/2002 | CA2435888A1 Method of preparing biological materials and preparation produced using same |
08/01/2002 | CA2435776A1 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines |
08/01/2002 | CA2435622A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
08/01/2002 | CA2435047A1 Constitutively desensitized g protein-coupled receptors |
08/01/2002 | CA2433681A1 Sulfatases and methods of use thereof |
08/01/2002 | CA2432134A1 Adenylate cyclases |
08/01/2002 | CA2431493A1 Aminoacyl trna synthetases |
08/01/2002 | CA2431144A1 Cell adhesion proteins |
08/01/2002 | CA2430762A1 Colon cancer marker |
08/01/2002 | CA2430743A1 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses thereof |
08/01/2002 | CA2429779A1 Adipocyte complement related protein zacrp13 |
08/01/2002 | CA2429397A1 Methods and means for producing efficient silencing construct using recombinational cloning |
08/01/2002 | CA2427676A1 Dna encoding human alpha and beta subunits of neuronal nicotinic acetylcholine receptor, cells transformed therewith, and recombinant cell line expressing a human alpha and beta subunits of neuronal nicotinic acetylcholine receptor |
08/01/2002 | CA2427647A1 Nucleic acid modification enzymes |
08/01/2002 | CA2426102A1 Method of diagnosing and treating cartilaginous disorders |
07/31/2002 | EP1227324A2 Har A polypeptides and nucleic acids and related methods and uses thereof |
07/31/2002 | EP1227323A1 Non-A, non-B hepatitis virus antigen, diagnostic methods and vaccines |
07/31/2002 | EP1227158A1 Method for degrading polylactate resins |
07/31/2002 | EP1227155A1 Process for producing ubiquinone-10 |
07/31/2002 | EP1227154A2 Bacillus thuringiensis strains active against lepidopteran and coleopteran pests |
07/31/2002 | EP1227152A1 Bacterial strain and genome of bifidobacterium |
07/31/2002 | EP1227147A2 Recombinational cloning using engineered recombination sites |
07/31/2002 | EP1226884A2 Decontamination bag for soil |
07/31/2002 | EP1226441A1 Protein tyrosine kinase receptor polynucleotides, polypeptides, and antibodies |
07/31/2002 | EP1226436A2 Universal fluorescent sensors |
07/31/2002 | EP1226435A1 Axor35, a g-protein coupled receptor |
07/31/2002 | EP1226277A2 A method for high-density microarray mediated gene expression profiling |
07/31/2002 | EP1226267A1 Process for producing a product containing antihypertensive tripeptides |
07/31/2002 | EP1226265A2 Bioproduction of para-hydroxycinnamic acid |
07/31/2002 | EP1226263A1 Invasive bacterial vectors for expressing alphavirus replicons |
07/31/2002 | EP1226262A2 Regeneration |
07/31/2002 | EP1226257A2 Screening and use of agents which block or activate intein splicing utilizing natural or homologous exteins |
07/31/2002 | EP1226250A2 Gpcr-kd5 polypeptides and dna sequences thereof |
07/31/2002 | EP1226249A2 Follistatin-related protein zfsta4 |
07/31/2002 | EP1226248A1 Cloning, expression and characterisation of a gene expressed in tumour cells and involved in the regulation of the immune response |
07/31/2002 | EP1226247A1 Human gpr27-like g-protein coupled receptor polypeptide and polynucleotide sequences |
07/31/2002 | EP1226246A1 Polypeptides with expanded primary signalling motifs |
07/31/2002 | EP1226245A2 Hybrid adaptor receptors |
07/31/2002 | EP1226244A2 Polypeptides with non-natural primary signalling motifs |
07/31/2002 | EP1226243A2 Nucleic acid molecules derived from rat brain and programmed cell death models |
07/31/2002 | EP1226236A1 Polypeptides having glucanotransferase activity and nucleic acids encoding same |
07/31/2002 | EP1226231A1 19 human secreted proteins |
07/31/2002 | EP1226230A1 Lactobacillus helveticus producing antihypertensive di- and tripeptides |
07/31/2002 | EP1226229A1 Method of freeze-drying different microorganisms |
07/31/2002 | EP1226227A2 Method for cultivating cells, a membrane module, utilization of a membrane module and reaction system for cultivation of said cells |
07/31/2002 | EP1226177A2 Anti-prostate stem cell antigen (psca) antibody compositions and methods of use |